Yahoo
Swiss - Delayed Quote CHF

Straumann Holding AG (STMN.SW)

96.60 -1.06 (-1.09%)
At close: 5:30:07 PM GMT+1
STMN.SW Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for STMN.SW
  • Previous Close 97.66
  • Open 96.40
  • Bid --
  • Ask 96.82 x --
  • Day's Range 94.82 - 99.00
  • 52 Week Range 73.02 - 109.80
  • Volume 475,611
  • Avg. Volume 382,070
  • Market Cap (intraday) 15.403B
  • Beta (5Y Monthly) 1.36
  • PE Ratio (TTM) 41.82
  • EPS (TTM) 2.31
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield 1.00 (1.02%)
  • Ex-Dividend Date Apr 21, 2026
  • 1y Target Est 113.21

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

www.straumann.com

11,582

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

STMN.SW
4.51%
MSCI WORLD (^990100-USD-STRD)
10.74%

1-Year Return

STMN.SW
9.16%
MSCI WORLD (^990100-USD-STRD)
11.73%

3-Year Return

STMN.SW
3.54%
MSCI WORLD (^990100-USD-STRD)
80.71%

5-Year Return

STMN.SW
46.85%
MSCI WORLD (^990100-USD-STRD)
56.62%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 706.47M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
0.0%

Analyst Insights

View More

Analyst Price Targets

88.00 Low
113.21 Average
96.60 Current
136.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/27/2026
  • Market Cap

    15.57B

  • Enterprise Value

    15.67B

  • Trailing P/E

    42.28

  • Forward P/E

    25.24

  • PEG Ratio (current)

    70.53

  • Price/Sales (ttm)

    5.91

  • Price/Book (mrq)

    6.83

  • Enterprise Value/Revenue

    5.94

  • Enterprise Value/EBITDA

    24.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.00%

  • Return on Assets (ttm)

    10.99%

  • Return on Equity (ttm)

    17.05%

  • Revenue (ttm)

    2.64B

  • Net Income Avi to Common (ttm)

    369.18M

  • Diluted EPS (ttm)

    2.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    414.6M

  • Total Debt/Equity (mrq)

    20.76%

  • Levered Free Cash Flow (ttm)

    399.02M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: